title: The Effect of Perinatal Hypoxic/Ischemic Injury on Tyrosine Hydroxylase Expression in the Locus Coeruleus of the Human Neonate.
abstract: We have previously shown that perinatal hypoxic/ischemic injury (HII) may cause selective vulnerability of the mesencephalic dopaminergic neurons of human neonate. In the present study, we investigated the effect of perinatal HII on the noradrenergic neurons of the locus coeruleus (LC) of the same sample. We studied immunohistochemically the expression of tyrosine hydroxylase (TH, first limiting enzyme for catecholamine synthesis) in LC neurons of 15 autopsied infants (brains collected from the Greek Brain Bank) in relation to the neuropathological changes of acute or chronic HII of the neonatal brain. Our results showed that perinatal HII appears to affect the expression of TH and the size of LC neurons of the human neonate. In subjects with neuropathological lesions consistent with abrupt/severe HII, intense TH immunoreactivity was found in almost all neurons of the LC. In most of the neonates with neuropathological changes of prolonged or older injury, however, reduction in cell size and a decrease or absence of TH staining were observed in the LC. Intense TH immunoreactivity was found in the LC of 3 infants of the latter group, who interestingly had a longer survival time and had been treated with anticonvulsant drugs. Based on our observations and in view of experimental evidence indicating that the reduction of TH-immunoreactive neurons occurring in the LC after perinatal hypoxic insults persists into adulthood, we suggest that a dysregulation of monoaminergic neurotransmission in critical periods of brain development in humans is likely to predispose the survivors of perinatal HII, in combination with genetic susceptibility, to psychiatric and/or neurological disorders later in life.
authors.affiliation: 1st Department of Psychiatry, National Kapodistrian University of Athens, Athens, Greece.
authors.forename: Marianna A
authors.initials: MA
authors.lastname: Pagida
authors.forename: Anastasia E
authors.initials: AE
authors.lastname: Konstantinidou
authors.forename: Anna
authors.initials: A
authors.lastname: Korelidou
authors.forename: Dimitra
authors.initials: D
authors.lastname: Katsika
authors.forename: Effrosini
authors.initials: E
authors.lastname: Tsekoura
authors.forename: Efstratios
authors.initials: E
authors.lastname: Patsouris
authors.forename: Maria T
authors.initials: MT
authors.lastname: Panayotacopoulou
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism*; D002545:Brain Ischemia / Q000188:drug therapy / Q000378:metabolism*; D002675:Child, Preschool; D059290:Dopaminergic Neurons / Q000378:metabolism*; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000378:metabolism*; D007223:Infant; D008125:Locus Coeruleus / Q000254:growth & development / Q000378:metabolism*; D008297:Male; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
chemical_list: D000927:Anticonvulsants; D014446:Tyrosine 3-Monooxygenase